As of 2025-12-29, the Relative Valuation of Merck & Co Inc (MRK) is 166.44 USD. This relative valuation is based on P/E multiples. With the latest stock price at 106.78 USD, the upside of Merck & Co Inc based on Relative Valuation is 55.9%.
The range of the Relative Valuation is 129.55 - 270.86 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.0x - 35.3x | 25.5x |
| Forward P/E multiples | 18.8x - 21.1x | 20.0x |
| Fair Price | 129.55 - 270.86 | 166.44 |
| Upside | 21.3% - 153.7% | 55.9% |
| Date | P/E |
| 2025-12-26 | 13.92 |
| 2025-12-24 | 13.88 |
| 2025-12-23 | 13.70 |
| 2025-12-22 | 13.66 |
| 2025-12-19 | 13.18 |
| 2025-12-18 | 13.13 |
| 2025-12-17 | 12.93 |
| 2025-12-16 | 12.81 |
| 2025-12-15 | 13.07 |
| 2025-12-12 | 13.08 |
| 2025-12-11 | 12.91 |
| 2025-12-10 | 12.73 |
| 2025-12-09 | 12.63 |
| 2025-12-08 | 12.90 |
| 2025-12-05 | 13.00 |
| 2025-12-04 | 13.16 |
| 2025-12-03 | 13.34 |
| 2025-12-02 | 13.17 |
| 2025-12-01 | 13.28 |
| 2025-11-28 | 13.67 |
| 2025-11-26 | 13.64 |
| 2025-11-25 | 13.78 |
| 2025-11-24 | 13.09 |
| 2025-11-21 | 12.75 |
| 2025-11-20 | 12.38 |
| 2025-11-19 | 12.39 |
| 2025-11-18 | 12.57 |
| 2025-11-17 | 12.11 |
| 2025-11-14 | 12.12 |
| 2025-11-13 | 12.12 |
| 2025-11-12 | 11.93 |
| 2025-11-11 | 11.86 |
| 2025-11-10 | 11.31 |
| 2025-11-07 | 11.25 |
| 2025-11-06 | 11.19 |
| 2025-11-05 | 11.00 |
| 2025-11-04 | 10.94 |
| 2025-11-03 | 10.76 |
| 2025-10-31 | 11.21 |
| 2025-10-30 | 11.25 |
| 2025-10-29 | 11.29 |
| 2025-10-28 | 11.35 |
| 2025-10-27 | 11.48 |
| 2025-10-24 | 11.41 |
| 2025-10-23 | 11.37 |
| 2025-10-22 | 11.42 |
| 2025-10-21 | 11.43 |
| 2025-10-20 | 11.26 |
| 2025-10-17 | 11.06 |
| 2025-10-16 | 10.94 |